News for 'Dr Reddys'

Markets snap 2-day rally; post 3rd weekly gains

Markets snap 2-day rally; post 3rd weekly gains

Rediff.com8 Jun 2018

Sun Pharma was by far the biggest gainer in the Sensex pack, surging 8.13 per cent, followed by Dr Reddy's at 4.92 per cent.

'Fact finding' team in Bengal to disturb peace, says Mamata; BJP hits back

'Fact finding' team in Bengal to disturb peace, says Mamata; BJP hits back

Rediff.com11 Apr 2023

Questioning the team's authority headed by a former Patna high court judge, Banerjee pointed out that Ram Navami processions organised by the Bharatiya Janata Party had carried arms and driven tractors and deliberately taken routes where 'Namaz' was being offered.

India successfully tests nuclear-capable ballistic missile 'Agni P'

India successfully tests nuclear-capable ballistic missile 'Agni P'

Rediff.com18 Dec 2021

The 'Agni P' is a two-stage canisterised solid propellant ballistic missile with dual redundant navigation and guidance system.

India likely to have Covid vaccine in new year: DCGI

India likely to have Covid vaccine in new year: DCGI

Rediff.com31 Dec 2020

The Serum Institute of India, Bharat Biotech and Pfizer have applied to the DCGI seeking emergency use authorisation for their COVID-19 vaccine candidates and are awaiting approval.

Sensex, Nifty end at fresh highs for 2nd straight session

Sensex, Nifty end at fresh highs for 2nd straight session

Rediff.com5 Jun 2017

TCS, Bajaj Auto, Adani Ports and Cipla were the top gainers on BSE Sensex while Coal India, GAIL, Dr Reddy's and Infosys lost the most on the index.

COVID-19 vaccines likely to have longer shelf life

COVID-19 vaccines likely to have longer shelf life

Rediff.com14 Dec 2020

A longer shelf life is critical, given many makers have started manufacturing vaccines and stockpiling them, so as to make them available in the market immediately after approval, reports Sohini Das.

ASK AJIT: Stocks To Buy, Hold, Sell

ASK AJIT: Stocks To Buy, Hold, Sell

Rediff.com11 Mar 2022

Ajit Mishra, vice president, Research, Religare Broking, answers your stock market queries.

When Kejriwal Met Modi...

When Kejriwal Met Modi...

Rediff.com6 Dec 2022

What some of our political leaders were up to on Monday.

PM discusses Covid vaccine strategy with CMs

PM discusses Covid vaccine strategy with CMs

Rediff.com24 Nov 2020

The modalities of COVID-19 vaccine delivery, distribution and administration were discussed during the meeting.

Markets clock highest gain since Oct on US Fed stance

Markets clock highest gain since Oct on US Fed stance

Rediff.com19 Nov 2015

Indian equity markets registered their highest single-day percentage gains since early October.

Does India have enough jabs to expand vaccination drive?

Does India have enough jabs to expand vaccination drive?

Rediff.com3 Jan 2022

A back of the envelope calculation shows that India has roughly over 680 million doses of Covid-19 vaccines consisting primarily of Covishield doses.

8 vaccines, 4 treatments in India's COVID-19 arsenal

8 vaccines, 4 treatments in India's COVID-19 arsenal

Rediff.com28 Dec 2021

The Central Drugs Standard Control Organisation has granted restricted emergency use authorisation to two new vaccines and a drug for COVID-19, taking the number of preventives and treatments available in India to 12.

Sensex advances for sixth day, IT the bright spot

Sensex advances for sixth day, IT the bright spot

Rediff.com23 Nov 2017

The 50-share NSE Nifty after moving between 10,374.30 and 10,307.30 settled flat at 10,348.75, up 6.45 points, or 0.06 per cent.

CoWIN portal in Hindi, other languages from next week: Govt

CoWIN portal in Hindi, other languages from next week: Govt

Rediff.com17 May 2021

The CoWIN portal will be made available in Hindi and 14 regional languages by next week, while 17 more laboratories will be added to the INSACOG network to monitor the variants of COVID-19, the health ministry said on Monday.

Sensex gains 593 points; crosses 55,000 for the first time

Sensex gains 593 points; crosses 55,000 for the first time

Rediff.com13 Aug 2021

TCS was the top gainer in the Sensex pack, rising over 3 per cent, followed by L&T, Bharti AIrtel, HCL Tech, Tata Steel, Bajaj Auto and Reliance Industries. NSE Nifty rallied 164.70 points to its fresh closing peak of 16,529.10.

COVID-19: 'There will be some spikes'

COVID-19: 'There will be some spikes'

Rediff.com19 Feb 2021

'It is absolutely important for us to continue to message to people that they must wear masks, keep physical distancing, as much as is practically possible, at work or at home.'

Family-owned companies weathering Covid-19 pandemic storm better

Family-owned companies weathering Covid-19 pandemic storm better

Rediff.com10 Sep 2020

Such businesses outperform non-family firms by 3% in first six months of CY20, says Credit Suisse report.

Sensex, Nifty log gains, break 2-day slide

Sensex, Nifty log gains, break 2-day slide

Rediff.com4 Aug 2017

Results of some blue-chip companies exceeded expectations, providing additional thrust, traders said.

Can bodies thrown in Ganga spread COVID?

Can bodies thrown in Ganga spread COVID?

Rediff.com15 May 2021

'We cannot have bodies putrefying in water.' 'This is a health hazard and it can create a very inflammatory situation.'

Covid drug sales shine even as market slows

Covid drug sales shine even as market slows

Rediff.com18 Aug 2020

Fabiflu sales have grown by 62 per cent in July. It was launched in June. This drug is being used by doctors for mild-to-moderate Covid patients even if they are in home isolation.

Cipla to price Remdesivir for Covid-19 under Rs 5,000

Cipla to price Remdesivir for Covid-19 under Rs 5,000

Rediff.com25 Jun 2020

Hetero has priced the injectable drug at Rs 5,400 per 100 mg vial. With More drugmakers in line to launch the drug soon, the prices may see a further erosion.

Sensex ends 184 points higher led by IT; Infosys up 5%

Sensex ends 184 points higher led by IT; Infosys up 5%

Rediff.com9 Jan 2015

Infosys, TCS, HUL and Reliance Industries were the top gainers of the day.

Karnataka polls: Siddaramaiah, Shivakumar figure in Cong first list

Karnataka polls: Siddaramaiah, Shivakumar figure in Cong first list

Rediff.com25 Mar 2023

While Shivakumar is as usual contesting from Kanakapura, Siddaramaiah is returning to his home turf of Varuna in Mysuru district, which is currently represented by his son Dr Yathindra Siddaramaiah.

First-time investor: 'I can afford only low-price stocks'

First-time investor: 'I can afford only low-price stocks'

Rediff.com12 Jan 2021

Ajit Mishra, vice president, Research, Religare Broking, answers your queries.

Why 60% of large-cap schemes underperformed the Nifty100 index in CY20

Why 60% of large-cap schemes underperformed the Nifty100 index in CY20

Rediff.com4 Jan 2021

Polarisation and the increase in index weight of a few a stocks have weighed on performance. The worst performers include Nippon India Large Cap and HDFC Top 100 (2.6 per cent).

Andhra doctor says he won't leave Ukraine without his leopard, panther

Andhra doctor says he won't leave Ukraine without his leopard, panther

Rediff.com7 Mar 2022

Dr Kumar says it's not just the question of his safety or survival but that of 'my precious big cats'.

Pharma in 2014: Deals worth billions and fines worth millions

Pharma in 2014: Deals worth billions and fines worth millions

Rediff.com26 Dec 2014

In a surprise announcement in April, Sun and Ranbaxy -- at that time owned by Japan's Daiichi -- declared an all-stock deal to create India's largest and world's fifth-largest drugmaker in an over $4 billion deal.

India's first mRNA vaccine gets nod for human trials

India's first mRNA vaccine gets nod for human trials

Rediff.com12 Dec 2020

The novel mRNA vaccine candidate, HGCO19, is supported with seed grant under the Ind-CEPI mission of the Department of Biotechnology. The mRNA vaccines do not use the conventional model to produce immune response. Instead, they carry molecular instructions to make the protein in the body through a synthetic RNA of the virus.

Sensex closes flat on special trading day

Sensex closes flat on special trading day

Rediff.com22 Mar 2014

In a range-bound trading, the BSE benchmark Sensex ended a shade higher by 1.57 points in the special 90-minute trading today as funds refrained from making any major commitments in the absence of global cues.

Sensex, Nifty stay afloat in volatile trade

Sensex, Nifty stay afloat in volatile trade

Rediff.com20 Nov 2017

The NSE 50-share after moving between 10,309.85 and 10,261.50 on alternate bouts of selling and buying, finished at 10,298.75, with paltry gains of 15.15 points, or 0.15 per cent.

Microsoft to work with T-Hub to develop startups: Nadell

Microsoft to work with T-Hub to develop startups: Nadell

Rediff.com28 Dec 2015

Nadella advised the start-up community to learn from the failures

What Is Your 2024 Game Plan, Modiji?

What Is Your 2024 Game Plan, Modiji?

Rediff.com4 Dec 2023

By keeping the Sanatana Dharma row alive and adding the Ayodhya temple consecration scheduled for January 22 and adding the free darshan promise from four polled states to the entire country, the BJP may have a self-fulfilling concoction, predicts N Sathiya Moorthy.

Coal scam: 'CBI is incapable of finding the truth'

Coal scam: 'CBI is incapable of finding the truth'

Rediff.com13 Jul 2017

'Officers have been made the scapegoat for political failure.' 'No effort has been made to find out who scuttled the prime minister's decision to introduce competitive bidding and why and at whose instance.'

Ram Charan Enjoys A Meal With BSF Jawans

Ram Charan Enjoys A Meal With BSF Jawans

Rediff.com20 Apr 2022

The movie star took a break from a film shoot in Amritsar to visit a BSF campus.

Meeting 1.35 bn vax dose target in Aug-Dec a long haul

Meeting 1.35 bn vax dose target in Aug-Dec a long haul

Rediff.com6 Aug 2021

While Covishield supplies would meet the target of 500 mn doses between August and December, it looks like Covaxin would miss the target of 400 mn unless the partner sites of Bharat Biotech ramp up very rapidly, reports Sohini Das.

Markets end higher on rate-cut hopes; RBI policy eyed

Markets end higher on rate-cut hopes; RBI policy eyed

Rediff.com3 Aug 2015

On the sectoral front, rate-sensitive sectors such as Bankex and Auto gained by 1% and 0.7% respectively while BSE Consumer Durables gained 1.4%.

Jagan cancels move to rename Abdul Kalam award

Jagan cancels move to rename Abdul Kalam award

Rediff.com6 Nov 2019

Soon after the above government order was released, the Opposition strongly condemned the move.

Greece impact: India Inc stares at weakening euro

Greece impact: India Inc stares at weakening euro

Rediff.com30 Jun 2015

Motherson Sumi, Tata Steel, Jaguar Land Rover will face higher cost.

Mayhem! Investors lose Rs 2 trillion as markets go into a tailspin

Mayhem! Investors lose Rs 2 trillion as markets go into a tailspin

Rediff.com12 May 2015

Investors lost Rs 2 trillion as Sensex crashed on Tuesday.

V G Somani: The head of DCGI known as man of actions, not of words

V G Somani: The head of DCGI known as man of actions, not of words

Rediff.com18 Jan 2021

'Safety is my first priority.' 'I need to ensure that any drug or vaccine that our citizens get is first safe.'